Quick Heal Technologies Ltd (BOM:539678)
₹ 655.75 -33 (-4.79%) Market Cap: 35.28 Bil Enterprise Value: 33.08 Bil PE Ratio: 87.44 PB Ratio: 8.14 GF Score: 71/100

Q4 2024 Quick Heal Technologies Ltd Earnings Call Transcript

Apr 26, 2024 / 10:30AM GMT
Release Date Price: ₹498.5 (-1.45%)

Key Points

Positve
  • Quick Heal Technologies Ltd (BOM:539678) reported a 5% growth in revenue for FY24.
  • EBITDA increased significantly, reaching 9 times the previous year's figure.
  • The company onboarded over 200 enterprise clients for new products in FY24.
  • Quick Heal Technologies Ltd (BOM:539678) has a strong balance sheet with zero debt and cash equivalents of INR 226 crores.
  • Strategic partnerships with IIM Nagpur, National Forensic Science University, and the US NIST Cybersecurity center for excellence were announced.
Negative
  • Headwinds in the consumer business persist, affecting overall growth.
  • Operating expenses increased from INR 12 crores to INR 14 crores quarter-on-quarter due to provisions for bad debts.
  • Some government deals were deferred to Q2 FY25 due to the general elections code of conduct.
  • The company is in an investment phase, making it difficult to provide specific margin guidance for FY25.
  • The enterprise business growth is slower than expected, with uncertainties around government deal closures.
Operator

And good day, and welcome to Quick Heal Technologies Limited Q4 and FY24 earnings conference call. (Operator Instructions)

I now hand the conference over to Ms. Purvan gi Jain from Valorem Advisors. Thank you, and over to you, ma'am.

Purvangi Jain
Valorem Advisors - Analyst

Good evening, everyone, and a warm welcome to you all. My name is Purvangi Jain from Valorem Advisors. We represent the Investor Relations of Quick Heal Technologies Limited. On behalf of the company, I would like to thank you all for participating in the company's earnings call for the fourth quarter of the financial year 2024.

Before we begin a quick cautionary statement, some of the statements made in today's earnings conference call may be forward-looking in nature. Such forward-looking statements are subject to risks and uncertainties which could cause actual results to differ from those anticipated. Such statements are based on management's beliefs as well as assumptions made by and information currently available to the management.

Audiences are cautioned

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot